NPI: 1205895661 · DURHAM, NC 27701 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/22/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/22/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,017 | $330K |
| 2019 | 18,663 | $314K |
| 2020 | 15,792 | $223K |
| 2021 | 12,883 | $205K |
| 2022 | 8,308 | $260K |
| 2023 | 3,355 | $275K |
| 2024 | 1,457 | $86K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 32,123 | 2,603 | $1.48M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 24,040 | 1,491 | $140K |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,930 | 1,356 | $32K |
| J1756 | Injection, iron sucrose, 1 mg | 4,736 | 1,260 | $24K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 224 | 141 | $11K |
| A4657 | Syringe, with or without needle, each | 1,309 | 1,056 | $4K |
| 83970 | 588 | 538 | $0.00 | |
| 82108 | 152 | 138 | $0.00 | |
| 85048 | 641 | 601 | $0.00 | |
| 85041 | 640 | 599 | $0.00 | |
| 83540 | 333 | 304 | $0.00 | |
| 83550 | 333 | 304 | $0.00 | |
| 82728 | 336 | 308 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 78 | 44 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 12 | 12 | $0.00 |